We are very honoured to count GENFIT among the Sponsors of BioFIT.

Many thanks to GENFIT for joining BioFIT 2017 as a bronze sponsor!

GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology.

Join key BioFIT 2017 sponsors such as Pfizer, Bayer, Lilly, Roche, MSD, Merck, Boehringer Ingelheim, Johnson & Johnson Innovation, Novo Nordisk, LFB, PPRS and Trianni to have the opportunity to:

Identify your organisation with the main partnering event in Europe dedicated to tech transfer, academia-industry collaborations, early-stage innovations and seed investment in Life Sciences
Highlight your interest in early-stage innovation
Present your ideas and technologies to key innovation players in Life Sciences
Enhance your visibility on an international scale and be recognised as a key innovative actor
Show your expertise thanks to specific communication tools

For more information about the sponsorship opportunities, visit the dedicated site page.

We are very honoured to count GENFIT among the Sponsors of BioFIT. Read More »

Check out the new BioFIT’s 2017 hosted event!

News / Valentine Delabie

We are delighted to host the LabEx Medalis conference during BioFIT 2017

BioFIT is proud to host LabEx Medalis for this edition in Strasbourg.

The Drug research center Medalis is a “Laboratory of Excellence” (Labex) created in July 2011 as part of the French program “Investments for the Future”. It is a member of “Initiatives of excellence” (IDEX) in the University of Strasbourg. The aim of the company is to develop innovative drugs for cancer or inflammation treatment.

On the 28^th of November will be held 3 conferences introduced by LabEx Medalis:
– Session 1: Translational research at Medalis: From lab to biotech
– Session 2: Early projects, early opportunity: Find your match
– Session 3: Nature and nurture of an Academic drug discovery Center

For more information about the sessions visit the dedicated site page.

Check out the new BioFIT’s 2017 hosted event! Read More »

Discover the BioFIT LinkedIn’s group

News / Valentine Delabie

BioFIT is now on LinkedIn!

This is the new BioFIT group on LinkedIn : BioFIT | A 360° approach to source Life Sciences early-stage innovations.

You will find there all the latest news of the event and you will be able to :

connect
share ideas
discuss

with all the members.

Do not hesitate to invite your connections to join this group!

Discover the BioFIT LinkedIn’s group Read More »

“BioFIT is for us a good platform to meet with potential partners” Juliane Proft, project manager at IOCB

News / Valentine Delabie

Juliane Proft is Project Manager in Oncology at IOCB (Institute of Organic Chemistry and Biochemistry), located in Prague, Czech Republic. IOCB is joining us to the 6^th BioFit edition in order to present its technology, open for co-development and out licensing contact. She accepted to share with us the reasons why IOCB comes to BioFIT.

BioFIT : What is IOCB ?

Juliane Proft : IOCB is a public research institution located in Prague, Czech Republic, part of the Academy of Sciences. In more than 60 years of its history it has been focused on fundamental research in Organic Chemistry, Biochemistry, Theoretical Chemistry and Chemistry of Natural compounds. The institute has also a tradition in the translation of results from basic research into practical applications, mainly in the field of human and veterinary medicine. A prominent example is Tenoforvir, an HIV drug developed in collaboration with the KU Leuven and Gilead Scientific. This translational effort continues, in 2017 we have signed license agreements with two major partners.

^{IOCB TTO Group © – Juliane (on the front) and the rest of the group of IOCB}

What are IOCB’s projects about ?

Most of our projects are developed around small molecules aiming at unmet medical needs like cancer, CNS diseases, viral and bacterial infections, metabolic syndrome and others. With around 40 research groups in various disciplines of chemistry, new projects are constantly evolving at the IOCB.

Why do you come to BioFIT ?

BioFIT is for us a good platform to meet with potential partners and we have made some fruitful connections in the past years. We are seeking for commercial partners to out-license and/or co-develop our technologies.

Many thanks to Juliane Proft for these comments.

“BioFIT is for us a good platform to meet with potential partners” Juliane Proft, project manager at IOCB Read More »

Enhance your presence at BioFIT: Book your exhibition stand today!

News / Valentine Delabie

Enhance your presence at BioFIT: Book your exhibition stand today!

Home » Archives for Valentine Delabie » Page 17

BioFIT will bring together, in Marseille on December 12^th and 13^th, and online on December 15^th, big pharma, emerging and small biotech, diagnostic companies, pre-seed, seed and Series A investors, as well as professionals from tech transfer, academia and research institutions from more than 35 countries. The event provides a unique opportunity to connect, network and explore new possibilities of partnering.

As an exhibitor, you will benefit from high visibility with key leaders in the Life Sciences sector.

Why should you book your stand today?

1️⃣ Showcase your innovative solutions to an international audience of decision-makers, investors, and potential collaborators.

2️⃣ Maximise your networking opportunities: meet leading experts, researchers, and industry professionals in the sector who can provide valuable insights, partnerships, and funding opportunities.

3️⃣ Highlight your organisation: by exhibiting at BioFIT you will benefit from extensive brand visibility (mention in our printed communication tools, highlight on the exhibition floor plan, additional visibility on our website) and recognition as a key player in the Life Sciences sector.

4️⃣ The early bird offer is still running, take advantage of a reduced fare before July 20^th

Availability is limited, our stands will be allocated on a first-come, first-served basis.

They already booked their stand: Atlanpole, BIOCentre, Boehringer Ingelheim, CER Groupe, Charles River Laboratoires, Drugabilis, Eurofins Scientific, Genfit, Innoser, Inrae Transfert, Microsynth, NovaliX, Paras Biopharmaceuticals Finland Oy, Pfizer, Porton Pharmaceutical Chemicals GmbH, Roowin, SIMV, WAINVAM-E, Zoetis, and many others…

Book your stand before July 20^th
to benefit from the Early Bird offer

You can also register as a delegate with the Early Bird offer before July 20^th, 2023.

If you are part of a BioFIT partner cluster or association, you can benefit from discounts on your pass:
contact them and register with their promo code.